Key Trend Reshaping the Panic Disorders Market in 2025: Pharmaceutical Companies Focus On Extended-Release Capsules For Panic Disorder Treatment Advancements

What Are the Projections for the Size and Growth Rate of the Panic Disorders Market?
The panic disorders market has seen steady growth in recent years. It will grow from $10.73 billion in 2024 to $11.19 billion in 2025, at a CAGR of 4.3%. The growth is attributed to the availability of antidepressant medications, increased mental health awareness, rising stress levels, improved access to mental health services, and advancements in diagnostic criteria.

The panic disorders market is expected to see strong growth, reaching $13.96 billion by 2029 at a CAGR of 5.7%. This growth is driven by emerging pharmacological treatments, the expansion of telepsychiatry services, attention to comorbidities, global mental health initiatives, pharmacogenomics in treatment, and public education programs. Key trends include digital mental health interventions, telemedicine adoption, innovations in medication, neurobiological research, and the use of remote monitoring and wearable technology.

What Are the Main Catalysts for Growth in the Panic Disorders Market?
The growing number of psychiatric patients is expected to contribute to the expansion of the panic disorder market. Psychiatric patients suffer from mental health disorders that affect their emotions, cognition, and social behavior, potentially leading to panic disorders characterized by intense, sudden episodes of fear. The treatment for panic disorders includes therapy, medication, and lifestyle adjustments to manage symptoms and enhance overall well-being. For instance, in October 2022, the State of Mental Health in America 2022 report by Mental Health America, a US-based nonprofit organization, indicated that the number of adults with mental illnesses in the U.S. rose to 49,564,000 in 2022, accounting for 19.86% of the total population, compared to 47,132,000 (19.00%) in 2021. Consequently, the rising number of psychiatric patients is driving the panic disorder market's growth.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

Which Businesses Are at the Forefront of Panic Disorders Market Development?
Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc., Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd., VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.

What Are the Latest Innovations in the Panic Disorders Market?
Prominent companies in the panic disorder market are emphasizing the development of advanced medications, such as extended-release capsules, to maintain their market position. Extended-release capsules are designed to release the active ingredient gradually over a period, typically 12 or 24 hours, to ensure sustained treatment. For instance, in May 2023, Granules India Ltd., an Indian pharmaceutical company, secured abbreviated new drug application (ANDA) approval from the US Food & Drug Administration (USFDA) for Venlafaxine hydrochloride extended-release capsules. These capsules have demonstrated bioequivalence with Effexor XR Extended-Release Capsules, the reference-listed drug manufactured by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are used to treat conditions such as generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They function by boosting serotonin and norepinephrine levels in the brain, with an initial dosage of 75 mg per day, which can be adjusted by doctors as needed.

How Is the Panic Disorders Market Segmented?
The panic disorders market covered in this report is segmented -

1) By Type: Agoraphobia, Social Anxiety Disorder (SAD), Obsessive-Compulsive Disorder (OCD), Bipolar Disorder, Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder
2) By Treatment: Medication, Beta Blockers, Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs), Benzodiazepines, Anti-Epilepsy, Other Treatments
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
4) By End Use: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacy Stores

Subsegments:
1) By Agoraphobia: Situational Agoraphobia, Non-Situational Agoraphobia
2) By Social Anxiety Disorder (SAD): Performance Anxiety, Generalized Social Anxiety
3) By Obsessive-Compulsive Disorder (OCD): Contamination OCD, Harm OCD, Checking OCD, Symmetry OCD
4) By Bipolar Disorder: Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder
5) By Post-Traumatic Stress Disorder (PTSD): Acute PTSD, Chronic PTSD, Complex PTSD
6) By Major Depressive Disorder: Recurrent Major Depressive Disorder, Single Episode Major Depressive Disorder

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

Where Is the Panic Disorders Market Growth Most Prominent?
North America was the largest region in the panic disorders market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Panic Disorders Global Market Report?

- Market Size Analysis: Analyze the Panic Disorders Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Panic Disorders Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Panic Disorders Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Panic Disorders Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13191

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.